Illumina advances MRD research portfolio with ultrasensitive duplex sequencing technology
ILMN•Illumina advanced its MRD research portfolio with ultrasensitive duplex sequencing technology.
1. Research portfolio
Illumina advanced its MRD research portfolio with ultrasensitive duplex sequencing technology.
